Page last updated: 2024-09-02

kt 6149 and Leukemia P388

kt 6149 has been researched along with Leukemia P388 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arai, H; Gomi, K; Inaba, M; Kasai, M; Kobayashi, E; Kono, M; Lee, JH; Okabe, M; Tsuruo, T1
Gomi, K; Hirata, T; Kasai, M; Kobayashi, S; Kono, M; Morimoto, M; Okumura, S; Takai, K; Ueno, H; Ushiki, J1
Arai, H; Ashizawa, T; Gomi, K; Kasai, M; Kobayashi, S; Okabe, M; Okamoto, A; Saito, H1
Asami, N; Inaba, M; Morimoto, M; Sudo, Y; Tsuruo, T1
Ashizawa, T; Kasai, M; Kono, M; Morimoto, M; Saitoh, Y; Sato, A; Shirahata, K1

Other Studies

5 other study(ies) available for kt 6149 and Leukemia P388

ArticleYear
Comparison of uptake of mitomycin C and KW-2149 by murine P388 leukemia cells sensitive or resistant to mitomycin C.
    Cancer chemotherapy and pharmacology, 1993, Volume: 32, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Division; DNA, Neoplasm; Drug Resistance; Leukemia P388; Membrane Glycoproteins; Mice; Mitomycin; Mitomycins; Tumor Cells, Cultured

1993
Disposition and metabolism of KW-2149, a novel anticancer agent.
    Cancer chemotherapy and pharmacology, 1993, Volume: 32, Issue:2

    Topics: Animals; Antineoplastic Agents; Female; Half-Life; HeLa Cells; Humans; Leukemia P388; Male; Mice; Mitomycin; Mitomycins; Spectrometry, Mass, Fast Atom Bombardment; Tissue Distribution

1993
Characteristics of the antitumor activity of M-16 and M-18, major metabolites of a new mitomycin C derivative KW-2149, in mice.
    Anti-cancer drugs, 1995, Volume: 6, Issue:6

    Topics: Animals; Antineoplastic Agents; Biotransformation; Breast Neoplasms; Cell Survival; HeLa Cells; Humans; Lethal Dose 50; Leukemia P388; Male; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred Strains; Mitomycin; Mitomycins; Rats; Sarcoma 180; Tumor Cells, Cultured

1995
Antitumor activity of a derivative of mitomycin, 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C (KW-2149), against murine and human tumors and a mitomycin C-resistant tumor in vitro and in vivo.
    Cancer chemotherapy and pharmacology, 1990, Volume: 27, Issue:2

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Body Weight; Colonic Neoplasms; Drug Screening Assays, Antitumor; Female; Humans; Leukemia P388; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Nude; Mitomycin; Mitomycins; Neoplasm Transplantation

1990
Synthesis and antitumor activity of a novel water soluble mitomycin analog; 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C.
    Chemical & pharmaceutical bulletin, 1989, Volume: 37, Issue:4

    Topics: Animals; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry; Leukemia P388; Mice; Mice, Inbred Strains; Mitomycins; Sarcoma 180

1989